Barclays’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$402K Buy
326,480
+98,131
+43% +$171K ﹤0.01% 3309
2025
Q4
$655K Buy
228,349
+177,938
+353% +$493K ﹤0.01% 3700
2025
Q3
$205K Sell
50,411
-16,589
-25% -$66.2K ﹤0.01% 4277
2025
Q2
$261K Buy
67,000
+4,822
+8% +$15.2K ﹤0.01% 4116
2025
Q1
$180K Sell
62,178
-29,134
-32% -$118K ﹤0.01% 4109
2024
Q4
$375K Buy
91,312
+9,396
+11% +$41.1K ﹤0.01% 3997
2024
Q3
$366K Buy
81,916
+62,354
+319% +$293K ﹤0.01% 3965
2024
Q2
$107K Sell
19,562
-24,260
-55% -$153K ﹤0.01% 3875
2024
Q1
$354K Sell
43,822
-29,926
-41% -$265K ﹤0.01% 3795
2023
Q4
$733K Buy
73,748
+57,963
+367% +$455K ﹤0.01% 3652
2023
Q3
$126K Sell
15,785
-939
-6% -$9.43K ﹤0.01% 3505
2023
Q2
$184K Sell
16,724
-31,780
-66% -$327K ﹤0.01% 3287
2023
Q1
$501K Buy
48,504
+46,555
+2,389% +$548K ﹤0.01% 3277
2022
Q4
$21.4K Sell
1,949
-318
-14% -$4.09K ﹤0.01% 4793
2022
Q3
$35K Sell
2,267
-874
-28% -$19.2K ﹤0.01% 3880
2022
Q2
$72K Buy
3,141
+2,809
+846% +$60.1K ﹤0.01% 3904
2022
Q1
$8K Buy
+332
New +$7.5K ﹤0.01% 4627

Other funds holding DH

Barclays's DH Position: Q1 2026 in Review

Barclays increased its Definitive Healthcare (DH) stake by 43% in Q1 2026, buying an estimated $171K and bringing the position to 326,480 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

Barclays first reported a position in DH in Q1 2022 and has held it in 17 quarters since. The position peaked at $733K in Q4 2023. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Barclays held 326,480 shares of Definitive Healthcare worth $402K as of Q1 2026.
  • Barclays bought 98,131 Definitive Healthcare shares in Q1 2026, an estimated $171K.
  • Definitive Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3309 holding.
  • Barclays first reported a position in Definitive Healthcare in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Definitive Healthcare position peaked at $733K in Q4 2023.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.